Cargando…
Heart failure with preserved ejection fraction update: A review of clinical trials and new therapeutic considerations
Between 2013 and 2016 there were approximately 6.2 million adults in the United States living with heart failure; nearly half had an ejection fraction that was preserved. Despite the high prevalence of heart failure with preserved ejection fraction (HFpEF), our understanding of this disease is limit...
Autores principales: | Maryniak, Andrii, Maisuradze, Nodari, Ahmed, Rafsan, Biskupski, Patrick, Jayaraj, Joseph, Budzikowski, Adam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273251/ https://www.ncbi.nlm.nih.gov/pubmed/35762077 http://dx.doi.org/10.5603/CJ.a2022.0051 |
Ejemplares similares
-
Decompensated Heart Failure as the Initial Presentation of Multiple Myeloma: A Case Report
por: Maisuradze, Nodari, et al.
Publicado: (2022) -
High-Degree Atrioventricular Block in a Patient With Asymptomatic COVID-19 Infection: A Case Report
por: Maisuradze, Nodari, et al.
Publicado: (2022) -
Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020) -
Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?
por: Ahmed, Talha
Publicado: (2020) -
Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety
por: Elkammash, Amr, et al.
Publicado: (2023)